What is the current Price Target for the Cns Pharmaceuticals Inc stock?

The average Cns Pharmaceuticals Inc target price is $53.04. This is 542.71% higher than the current stock price. The highest price target is 968.77%, the lowest is 144.77%. 4 Analysts have issued a price target Cns Pharmaceuticals Inc 2026 .

How high will the Cns Pharmaceuticals Inc stock rise?

No reliable answer can be given as to how high the Cns Pharmaceuticals Inc stock will rise. The performance of stocks, including the Cns Pharmaceuticals Inc stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Cns Pharmaceuticals Inc stock today?

The performance of Cns Pharmaceuticals Inc stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Cns Pharmaceuticals Inc stock fall?

The decline in Cns Pharmaceuticals Inc stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Cns Pharmaceuticals Inc Forecast, price target & analysts

$8.25

2.52% day before yesterday

Nasdaq, Oct 24, 10:00 pm CET

ISIN

US18978H1023

Symbol

CNSP

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Pharmaceuticals

Overview Dividends Analysts Charts News Strategies

Cns Pharmaceuticals Inc Target price 2025 - Analyst rating & recommendation

Cns Pharmaceuticals Inc Classifications & Recommendation:

Buy

88%

Hold

13%

Cns Pharmaceuticals Inc Price Target

Target Price	$53.04
Price	$8.25
Potential	542.71% register free of charge
Number of Estimates	4

	4 Analysts have issued a price target Cns Pharmaceuticals Inc 2026 . The average Cns Pharmaceuticals Inc target price is $53.04. This is 542.71% register free of charge higher than the current stock price. The highest price target is $88.20 968.77% register free of charge , the lowest is $20.20 144.77% register free of charge .
	A rating was issued by 8 analysts: 7 Analysts recommend Cns Pharmaceuticals Inc to buy, 1 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Cns Pharmaceuticals Inc stock has an average upside potential 2026 of 542.71% register free of charge . Most analysts recommend the Cns Pharmaceuticals Inc stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2028

Create a premium account to unlock analyst estimates. Learn more

Annually

	Dec '24	2025 Estimates
Earnings Per Share $	-466.49	-34.38
	99.68%	92.63%
P/E		negative

4 Analysts have issued a Cns Pharmaceuticals Inc forecast for earnings per share. The average Cns Pharmaceuticals Inc EPS is

Unlock

. This is

Unlock

than earnings per share in the financial year 2024. The highest EPS forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics and future valuations:

2024	$-466.49	99.68%
2025	$-34.38 92.63% Unlock
2026	$-10.38 69.81% Unlock
2027	$-9.34 10.02% Unlock
2028	$-25.34 171.31% Unlock

Current	-0.20	24.51%
2025	-0.24 21.46% Unlock
2026	-0.79 229.17% Unlock
2027	-0.88 11.39% Unlock
2028	-0.33 62.50% Unlock

Cns Pharmaceuticals Inc...

Current Cns Pharmaceuticals Inc Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
Maxim Group	Locked ➜ Locked	Locked	Sep 12 2025
Maxim Group	Locked ➜ Locked	Locked	Mar 25 2025
Maxim Group	Locked ➜ Locked	Locked	Sep 10 2024

Analyst Rating	Date
Locked Maxim Group: Locked ➜ Locked	Sep 12 2025
Locked Maxim Group: Locked ➜ Locked	Mar 25 2025
Locked Maxim Group: Locked ➜ Locked	Sep 10 2024

Discover more stocks with a high price target

TUI 50.73%

Deutsche Telekom 33.66%

Netflix 32.31%

BioNTech SE - ADR 32.25%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now